Effect of Atazanavir-ritonavir on the Pharmacokinetics and Toxicity of Lumefantrine

NCT04531072 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

20

Enrollment

NIH

Sponsor class

Conditions

Drug Interaction

Interventions

DRUG: Artemether-lumefantrine
DRUG: Atazanavir-ritonavir 300/100 mg

Sponsor

Fogarty International Center of the National Institute of Health

Collaborators

[object Object]
[object Object]
[object Object]